Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1210-1219

  Kawakami, Yuko ^a   Kitaura, Jiro ^a   Satterthwaite, Anne B ^b   Kato, Roberta M ^b   Asai, Koichi ^a   Hartman, Stephen E ^a   Maeda Yamamoto, Mari ^c   Lowell, Clifford A ^d   Rawlings, David J ^b   Witte, Owen N ^b   Kawakami, Toshiaki ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c National Institute of Vegetable and Tea Science   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; DEGRANULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0034254791     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1210     Document Type: Article

References (76)

1. Galli, S. J., and C. S. Lantz. 1998. Allergy. In Fundamental Immunology, 4th Ed. W. Paul, ed. Lippincott-Raven Publishers, Philadelphia, PA, p. 1127.
2. Ravetch, J. V., and J.-P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457.
3. Eiseman, E., and J. B. Bolen. 1992. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355:78.
4. Vonakis, B. M., H. Chen, H. Haleem-Smith, and H. Metzger. 1997. The unique domain as the site on Lyn kinase for its constituttive association with the high affinity receptor for IgE. J. Biol. Chem. 272:24072.
5. Pribluda, V., C. Pribluda, and H. Metzger. 1994. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA 91:11246.
6. Cambier, J. C. 1995. New nomenclature for the Reth motif (or ARHI/TAM/ ARAM/YXXL). Immunol. Today 16:110.
7. Jouvin, M.-H., M. Adamczewski, R. Numerof, O. Letourneur, A. Valle, and J.-P. Kinet. 1994. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J. Biol. Chem. 269:5918.
8. Kihara, H., and R. P. Siraganian. 1994. Src homlogy 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J. Biol. Chem. 269:22427.
9. Rowley, R. B., A. L. Burkhardt, H.-G. Chao, G. R. Matsueda, and J. B. Bolen. 1995. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Igα/ Igγ immunoreceptor tyrosine activation motif binding and autophosphorylation. J. Biol. Chem. 270:11590.
10. syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides. Mol. Cell. Biol. 16:1471.
11. El-Hilal, O., T. Kurosaki, H. Yamamura, J.-P. Kinet, and A. M. Scharenberg. 1997. Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc. Natl. Acad. Sci. USA 94:191.
12. 2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. J. Immunol. 158:2350.
13. Zhang, J., E. H. Berenstein, R. L. Evans, and R. P. Siraganian. 1996. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J. Exp. Med. 184:71.
14. Costello, P. S., M. Turner, A. E. Walters, C. N. Cunningham, P. H. Bauer, J. Downward, and V. L. J. Tybulewicz. 1996. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13:2595.
15. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693.
16. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268:1749.
17. Tsukada, S., D. Saffran, D. J. Rawlings, O. Parolini, R. C. Allen, I. Klisak, R. S. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agamma-globulinemia. Cell 72:279.
18. Vetrie, D., I. Vorechovsky, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarstrom, C. Kinnon, R. Levinsky, M. Bobrow, C. I. E. Smith, and D. R. Bentley. 1993. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 361:226.
19. Yamada, N., Y. Kawakami, H. Kimura, H. Fukamachi, G. Baier, A. Altman, T. Kato, Y. Inagaki, and T. Kawakami. 1993. Structure and expression of novel protein tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem. Biophys. Res. Commun. 192:231.
20. Thomas, J. D., P. Sideras, C. I. E. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355.
21. Rawlings, D. J., D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, N. A. Jenkins, and O. N. Witte. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodieficient XID mice. Science 261:358.
22. Hata, D., Y. Kawakami, N. Inagaki, C. S. Lantz, T. Kitamura, W. N. Khan. M. Maeda-Yamamoto, T. Miura, W. Han, S. E. Hartman, et al. 1998. Involvement of Bruton's tyrosine kinase in Fc∈RI-dependent mast cell degranulation and cytokine production. J. Exp. Med. 187:1235.
23. Takata, M., and T. Kurosaki. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184:31.
24. 2+ following B-cell receptor activation. EMBO J. 17:1973.
25. Kawakami, Y., T. Miura, R. Bissonnette, D. Hata, W. N. Khan, T. Kitamura, M. Maeda-Yamamoto, S. E. Hartman, L. Yao, F. W. Alt, and T. Kawakami. 1997. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc. Natl. Acad. Sci. USA 94:3938.
26. Hata, D., J. Kitaura, S. E. Hartman, Y. Kawakami, T. Yokota, and T. Kawakami. 1998. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells: dependence on the c-Jun N-terminal kinase activation pathway. J. Biol. Chem. 273:10979.
27. Rawlings, D. J., A. M. Scharenberg, H. Park, M. I. Wahl, S. Lin, R. M. Kato, A.-C. Fluckiger, O. N. Witte, and J.-P. Kinet. 1996. Activation of BTK by a phopshorylation mechanism initiated by SRC family kinases. Science 271:822.
28. Li, Z., M. I. Wahl, A. Eguinoa, L. R. Stephens, P. T. Hawkins, and O. N. Witte. 1997. Phosphatidylinositol 3-kinase-γ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. USA 94:13820.
29. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1961.
30. Park, H., M. I. Wahl, D. E. Afar, C. W. Turk, D. J. Rawlings, C. Tam, A. M. Scharenberg, J.-P. Kinet, and O. N. Wine. 1996. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4:515.
31. Chan, V. W. F., F. Meng, P. Soriano, A. L. Defranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69.
32. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549.
33. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Mueller, A. B. Kantor, L. A. Herzenberg, F. S. Rosen, and P. Sideras. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283.
34. Kerner, J. D., M. W. Appleby, R. N. Mohr, S. Chien, D. J. Rawlings, C. R. Maliszewski, O. N. Witte, and R. M. Perlmutter. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301.
35. Scher, I. 1982. The CBA/N mouse strain: an experimental model illustrating the influence of X chromosome on immunity. Adv. Immunol. 33:1.
36. Satterthwaite, A. B., C. A. Lowell, W. N. Khan, P. Sideras, F. W. Alt, and O. N. Witte. 1998. Independent and opposing roles for Btk and Lyn in B and myeloid signaling pathways. J. Exp. Med. 188:833.
37. Takeshita, H., I. Taniuchi, J. Kato, and T. Watanabe. 1998. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene. Int. Immunol. 10:435.
38. Chan, V. W. F., C. A. Lowell, and A. L. DeFranco. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8:545.
39. Smith, K. G. C., D. M. Tarlinton, G. M. Doody, M. L. Hibbs, and D. T. Fearon. 1998. Inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 187:807.
40. Nishizumi, H., K. Horikawa, I. Mlinaric-Rascan, and T. Yamamoto. 1998. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187:1343.
41. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497.
42. Rivera, J., J.-P. Kinet, J. Kim, C. Pucillo, and H. Metzger. 1988. Studies with a monoclonal antibody to the β subunit of the receptor with high affinity for immunoglobulin E. Mol. Immunol. 25:647.
43. Liao, X. C., D. R. Littman, and A. Weiss. 1997. Itk and Fyn make independent contributions to T cell activation. J. Exp. Med. 186:2069.
44. Kawakami, T, N. Inagaki, M. Takei, H. Fukamachi, K. M. Coggeshall, K. Ishizaka, and T. Ishizaka. 1992. Tyrosine phosphorylation is required for mast cell activation by Fc∈RI cross-linking. J. Immunol. 148:3513.
45. Siraganian, R. P. 1974. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem. 57:383.
46. Fukamachi, H., N. Yamada, T. Miura, T. Kato, M. Ishikawa, E. Gulbins, A. Altman, Y. Kawakami, and T. Kawakami. 1994. Identification of a protein, SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by Fc∈RI cross-linking. J. Immunol. 152:642.
47. Hsu, C., and M. MacGlashan, Jr. 1996. IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol. Lett. 52:129.
48. Yamaguchi, M., C. S. Lantz, H. C. Oettgen, I. M. Katona, T. Flemming, I. Miyajima, J.-P. Kinet, and S. J. Galli. 1997. IgE enhances mouse mast cell Fc∈RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 185:663.
49. Uckun, F. M., K. G. Waddick, S. Mahajan, X. Jun, M. Takata, J. Bolen, and T. Kurosaki. 1996. BTK as a radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273:1096.
50. Anderson, J. S., M. Teutsch, Z. Dong, and H. H. Wortis. 1996. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93:10966.
51. Vassilev, A., Z. Ozer, C. Navara, S. Mahajan, and F. M. Uckun. 1999. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J. Biol. Chem. 274:1646.
52. Beaven, M. A., and H. Metzger. 1993. Signal transduction by Fc receptors: the Fc∈RI case. Immunol. Today 14:222.
53. Scharenberg, A. M., and Kinet, J.-P. 1998. PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell 94:5.
54. 2+ mobilization through distinct pathways. EMBO J. 13:1341.
55. Schleimer R. P., E. Gillespie, and L. M. Lichtenstein. 1981. Release of histamine from human leukocytes stimulated with the tumor promoting phorhol esters. I. Characterization of the response. J. Immunol. 126:570.
56. Wershil, B. K., Z.-S. Wang, J. R. Gordon, and S. J. Galli. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α . J. Clin. Invest. 87:446.
57. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
58. Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296.
59. 2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 188:1297.
60. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251.
61. Xia, Z., M. Dickens, J. Raingeaud, R. J., Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326.
62. Chen, Y.-R., C. F. Meyer, and T.-H. Tan. 1996. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J. Biol. Chem. 271:631.
63. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, et al. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75.
64. Nishina, H., K. D. Fisher, L. Radvanyl, A. Shahinian, R. Hakem, E. A. Rubie, A. Bernstein, T. W. Mak, J. R. Woodgett and J. M. Penninger. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385:350.
65. 2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA 94:3004.
66. 2 pathway by Fc∈RI is not shared by a G protein-coupled receptor. J. Biol. Chem. 270:10960.
67. Katsuta, H., S. Tsuji, Y. Niho, T. Kurosaki, and D. Kitamura. 1998. Lyn-mediated down-regulation of B cell antigen receptor signaling: inhibition of protein kinase C activation by Lyn in a kinase-independent fashion. J. Immunol. 160: 1547.
68. Nechushtan, H., M. Leitges, C. Cohen, G. Kay, and E. Razin. 2000. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood. 95:1752.
69. Maeda, A., A. M. Scharenberg, S. Tsukada, J. B. Bolen, J.-P. Kinet, and T. Kurosaki. 1999. Paired immunoglobulin-like receptor B (P1R-B) inhibits BCR-induccd activation of Syk and Btk by SHP-1. Oncogene 18:2291.
70. Malbec, O., D. C. Fong, M. Turner, V. L. J. Tybulewicz, J. C. Cambier, W. H. Fridman, and M. Daeron. 1998. Fc∈ receptor I-associated lyn-dependent phosphorylation of Fcγ receptor IIB during negative regulation of mast cell activation. J. Immunol. 160:1647.
71. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179.
72. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:330.
73. Goldfeld, A. E., P. G. McCaffrey, J. L. Strominger, and A. Rao. 1993. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor α gene promoter. J. Exp. Med. 178:1365.
74. Tsai, E. Y., J. Jain, P. A. Pesavento, A. Rao, and A. E. Goldfeld. 1996. Tumor necrosis factor α gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol. Cell. Biol. 16:459.
75. Tsai, E. Y., J. Yie, D. Thanos, and A. E. Goldfeld. 1996. Cell-type-specific regulation of the human tumor necrosis factor or gene in B cells and T cells by NFATp and ATF-2/JUN. Mol. Cell. Biol. 16:5232.
76. 2-terminal kinase pathway. Science 280: 1945.